Expression of interleukin-15 in mouse and human atherosclerotic lesions

American Journal of Pathology

Volumn 159, Issue 2, 2001, Pages 417-423

  Wuttge, Dirk Marcus ^a   Eriksson, Per ^b   Sirsjö, Allan ^a   Hansson, Göran K ^a   Stemme, Sten ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 15; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

EID: 0034880076     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61712-9     Document Type: Article

References (50)

1. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
2. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
3. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice
4. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
5. Atherosclerosis - An inflammatory disease
6. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
7. The combined role of P- and E-selectins in atherosclerosis
8. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse
9. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
10. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
11. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
12. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
13. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1
14. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
15. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes
16. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions
17. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice
18. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
19. Interleukin 15: A proinflammatory role in rheumatoid arthritis synovitis
20. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
21. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo
22. Interleukin-15: A novel anabolic cytokine for skeletal muscle
23. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
24. Induction and regulation of IL-15 expression in murine macrophages
25. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils
26. The NF-kappaB binding site is essential for transcriptional activation of the IL-15 gene
27. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis
28. Chemoattraction of human blood T lymphocytes by interleukin-15
29. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse - Human rheumatoid arthritis model in vivo
30. Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo
31. Requirement for CD44 in activated T cell extravasation into an inflammatory site
32. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion
33. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment
34. Interleukin-15 promotes angiogenesis in vivo
35. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
36. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR
37. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production
38. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
39. Activation of naive and memory T cells by interleukin-15
40. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
41. Inhibition of keratinocyte apoptosis by IL-15: A new parameter in the pathogenesis of psoriasis?
42. Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death
43. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: Modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15
44. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation
45. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells
46. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
47. Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells
48. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens
49. CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells
50. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice